Archives
-
Puromycin in VSMC Translation Research
2026-09-17
A translational strategy for using Puromycin dihydrochloride to engineer, validate, and interpret vascular smooth muscle cell models centered on the TET2–SLC7A1–NRF2 axis in hypertension.
-
PXDN–LDHA Glycolysis in Glioblastoma
2026-09-17
The reference study identifies PXDN as a glycolysis-associated driver of glioblastoma progression and connects it mechanistically to LDHA expression. Its integrated bioinformatics, cellular, rescue, and in vivo design provides a framework for studying how metabolic remodeling supports malignant behavior, while ATP measurements can offer a complementary readout of cellular energy state.
-
PRDX5 Acetylation in Retinal Ischemia-Reperfusion
2026-09-16
The reference study identifies PRDX5 acetylation as a functionally important modifier of retinal ischemia-reperfusion injury, linking impaired antioxidant activity with neuronal oxidative stress and apoptosis. Its combination of an acute high-intraocular-pressure mouse model, OGD/R-treated R28 cells, genetic perturbation, and acetylation-focused pharmacology provides a useful framework for mechanistic retinal injury research.
-
Dye Models for Small Biopsy Visibility
2026-09-16
This 2023 study evaluated whether common histological dyes could improve the visibility of 0.2–0.3 cm tissue specimens during surgical pathology processing. Merbromin, hematoxylin, and Alcian blue improved specimen observability, but hematoxylin was favored because it combined useful marking performance with lower toxicity and no reported interference during routine slide review.
-
AST 487 and KDM4A in Mesothelioma Research
2026-09-15
AST 487 is cataloged as product A3194, but the supplied dossier does not establish its molecular target or activity against KDM4A. The cited mesothelioma study supports KDM4A as a preclinical dependency in malignant pleural mesothelioma and defines the evidence boundary for using this product in related experiments.
-
Nile Red for Lipid Droplet Imaging
2026-09-15
Nile Red, also called Nile blue oxazone, is a wavelength-dependent lipophilic fluorescent dye for intracellular lipid droplet staining and lipid distribution imaging. Its red and green fluorescence modes help distinguish broad membrane-associated signal from more selective lipid-droplet signal, but fluorescence alone does not quantify lipid metabolism or autophagic flux.
-
Phalloidin (B7678): F-Actin Workflow Guide
2026-09-14
Phalloidin (B7678) is a cyclic heptapeptide toxin that binds and stabilizes filamentous actin for fixed-cell, permeabilized-sample, tissue-section, and cell-free cytoskeleton visualization. It is not appropriate for live-cell imaging or experiments that require reversible actin turnover, because the reagent can promote filament stabilization and alter cytoskeletal dynamics.
-
Pemetrexed in Mesothelioma Assay Design
2026-09-14
Pemetrexed and pemetrexed disodium are examined through a mesothelioma assay-design lens, connecting folate-pathway stress with DNA-repair phenotypes. This guide translates a key malignant pleural mesothelioma study into practical decisions for cancer chemotherapy research.
-
PXDN, LDHA, and Glycolysis in Glioblastoma
2026-09-13
The reference study identifies peroxidasin (PXDN) as a glycolysis-associated driver of glioblastoma progression and places LDHA downstream of PXDN in this regulatory relationship. Its combination of transcriptomic screening, network analysis, loss-of-function experiments, in vivo validation, and LDHA rescue experiments provides a mechanistic framework for studying metabolic vulnerabilities in GBM.
-
Octenidine Dihydrochloride: Assay Design Guide
2026-09-12
Octenidine dihydrochloride is a membrane-active antiseptic research compound whose performance depends on chemistry, formulation, and assay design. This guide connects its gemini quaternary ammonium structure with reproducible antimicrobial workflows and practical interpretation of comparative data.
-
Dacomitinib: A Mechanism-Resolved Assay Strategy
2026-09-11
Dacomitinib (PF-00299804) enables durable ErbB signaling perturbation while supporting a carefully controlled comparison of apoptosis, cell-cycle arrest, and ferroptosis phenotypes. This guide connects pan-HER pharmacology with the METTL17–mitochondrial translation axis without overstating evidence across cancer models.
-
DAPI Nuclear Stain Solution: Practical Workflow
2026-09-11
DAPI (4',6-Diamidino-2-Phenylindole) Nuclear Stain Solution provides a ready-to-use fluorescent DNA binding dye for visualizing nuclei and assessing membrane compromise. It is best suited to fixed or membrane-compromised samples for fluorescence microscopy or flow cytometry, rather than routine imaging of intact live cells.
-
BRD4–RAC1 Co-targeting in Breast Cancer
2026-09-10
The reference study identifies combined BRD4 and RAC1 inhibition as a subtype-spanning strategy that suppresses breast cancer growth, stemness, migration, and tumorigenesis. Its mechanistic contribution is to connect BRD4–RAC1 blockade with disruption of the c-MYC–G9a–FTH1 axis and downregulation of HDAC1, providing a framework for interpreting coordinated epigenetic and oncogenic signaling.
-
L. gasseri and E-Cadherin in DSS Colitis
2026-09-10
Qian et al. identify a mechanistic link between Lactobacillus gasseri ATCC33323, NR1I3 activity, and E-cadherin regulation in a mouse model of DSS-induced colitis. The study combines physiological, barrier, microbiota, genetic perturbation, and transcriptional evidence to show how this strain may protect intestinal epithelial integrity, while also defining important limits for translation beyond the experimental model.
-
10 mM dNTP Mixture: Assay-Level Precision
2026-09-09
The 10 mM dNTP mixture is more than a convenient PCR nucleotide mix: it is a controlled chemical input for reproducible DNA synthesis and assay interpretation. This article connects nucleotide balance, polymerase behavior, and recent LNP delivery findings to practical experimental design.